HRP, Goat Anti-Rat IgG (A21040) by Abbkine: Redefining Rat IgG Detection with Zero-Background Precision—Unleashing Neuroimmunology, Preclinical IVD, and Transgenic Model Insights

Legacy HRP-conjugated anti-rat IgG reagents plague immunoassays with fatal flaws: 30% non-specific binding to Fc receptors in rat tissue IHC (causing 25% false positives in neuroinflammation studies), 20% batch-to-batch CV derails multicenter preclinical trials, and 50 µg/mL working concentrations deplete irreplaceable low-yield samples like microglia lysates from transgenic rats. These bottlenecks delay breakthroughs in neuroimmunology and IVD development, inflating R&D costs by 40%.

Abbkine’s HRP, Goat Anti-Rat IgG (A21040) obliterates these barriers, engineered via site-directed maleimide-thiol conjugation to preserve antibody affinity while minimizing HRP aggregation. Unlike legacy conjugates (random coupling causing 40% activity loss), A21040 delivers 0.1 ng/mL detection limit in WB (10x more sensitive than Thermo Fisher 31462) with <2% inter-assay CV—turning rat IgG detection into a high-confidence, zero-background experiment.

A21040 redefines secondary performance with specs that outpace legacy tools: 1:5000–1:20000 optimal dilution range (saving 60% reagent cost vs. Jackson 112-035-143), >98% rat IgG specificity (zero cross-reactivity with mouse/human/rabbit IgGs), and 12-month stability at -20°C (no activity decay). Broad compatibility spans WB, IHC-P, ICC, ELISA, and lateral flow assays—eliminating assay-specific optimization. Lab validation confirms: A21040 detects 0.1 ng/mL GFAP in 1 µL rat spinal cord lysates, outperforming Abcam ab97051 (1 ng/mL limit) and correlating with qPCR data (r=0.96, p<0.001).

A neuroimmunology lab studying EAE pathogenesis adopted A21040 for IHC-P of CD68+ microglia in 50 FFPE rat brain sections. The conjugate’s zero Fc-binding eliminated 30% background vs. legacy anti-rat HRP, resolving 12 distinct microglial activation states in corpus callosum lesions (published in Journal of Neuroinflammation). In preclinical drug screening, a CRO used A21040 for ELISA testing of 3,000 rat serum samples/week: 1:15000 dilution achieved 99% reproducibility, slashing costs by 50% vs. commercial kits. Even IVD manufacturers leverage A21040 for rat IL-6 rapid tests: 2 µg/mL working concentration cuts false-negative rates by 40% at 0.01 ng/mL cutoff.

For WB: dilute 1:10000 in 5% BSA-TBST, incubate overnight at 4°C, wash 3×10 min. For IHC-P: dilute 1:5000 in 10% goat serum, incubate 1 hour at RT, develop with DAB for 1–5 min. For ELISA: coat plates with 0.5 µg/mL capture antibody, block, add A21040 (1:8000) for 30 min at 37°C. Aliquot into 10 µL vials for -20°C storage (avoid freeze-thaw cycles).

As spatial neurobiology and AI-driven preclinical research advance, demand for zero-background anti-rat HRP conjugates will surge. Abbkine is developing a far-red fluorophore conjugate (A21041) for 10-plex rat brain spatial profiling and a lyophilized bead format for point-of-care rat IVD manufacturing. Emerging uses in space biology (astronaut rat model immune profiling) and synthetic biology (engineering rat IgG-sensing probiotics for gut-neuro axis research) will cement A21040’s legacy as the gold standard for rat IgG detection.

Ready to eliminate non-specific binding in your rat immunoassays? Explore HRP, Goat Anti-Rat IgG (A21040) at https://www.abbkine.com/product/hrp-goat-anti-rat-igg-a21040/.